ZYTOLIGHT
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79383070
- Registration number
- 7583067
- Mark type
- Stylized text
- Filed
- 12 Oct 2023
- Published for opposition
- 01 Oct 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Laurence P. Colton
Goods and services
- Class 005 — Pharmaceuticals: Medical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for veterinary diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; chemical preparations for veterinary purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic chemical reagents for medical use; chemical preparations for testing blood for blood disorders, tumor diseases, viruses, bacteria, disease diagnosis and detection, organ function, metabolic disorders, endocrine disorders, hormonal disorders, bacteria-based disorders, virus-based disorders, fungal infections for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic chemical test reagents for medical purposes; diagnostic chemical test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; diagnostic testing materials in the nature of diagnostic chemical and biological reagents for medical use; indicators for medical diagnosis in the nature of chemical and biological diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; reagents for use in diagnostic analysis for veterinary purposes; reagents for analytical diagnostic purposes for medical purposes; reagents for analytical diagnostic purposes for veterinary purposes; diagnostic reagents for in-vitro laboratory use for medical purposes; diagnostic reagents for in-vitro laboratory use for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for microbiological analysis for medical purposes; diagnostic reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic analysis for medical purposes; reagents for use in diagnostic tests for medical purposes; diagnostic reagents for use with analyzers for veterinary purposes; diagnostic reagents for use with analyzers for medical purposes; reactants for medical diagnosis; reactants for veterinary diagnosis; veterinary diagnostic reagents
Owner
- ZytoVision GmbH, DE
- ZytoVision GmbH, DE
- ZytoVision GmbH, DE
Prosecution history
- 24 May 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 06 May 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 06 May 2025 — FINAL DISPOSITION PROCESSED
- 26 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 08 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 03 Mar 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 29 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Aug 2024 — EXAMINERS AMENDMENT E-MAILED